Management Team

Image

Shai Meretzki, PhD - Chief Executive Officer and President

Former founder, CEO and CTO of Pluristem Therapeutics Inc. (OTCBB: PSTI) a cell therapy company, Dr. Meretzki brings broad technical and managerial experience in the biotechnology discipline. Dr. Meretzki has vast experience in biological and chemical R&D, specifically in the area of cell culture, ex-vivo tissue engineering and bone regeneration.He holds PhD and MSc degrees in Biotechnology from the Technion - Israel Institute of Technology in cooperation with the Weizmann Institute, Israel. He also serves as Chairman of the Board at Biological Industries Israel Beit HaEmek Ltd.

Yossi Rauch, MBA - Executive Chairman of the Board

Mr. Rauch served as Chief Economist and Manager of the Economics Department of Leumi PIA, Israel’s largest mutual fund company. He was also Manager of the Treasury Department of Koor-Trade, a group of international trade companies. Mr. Rauch holds an MBA in Finance & Accounting and Computers & Information Systems from Tel Aviv University, and a BA in Economics and Business Administration from Bar-Ilan University.

Image
Image

Yoni Livne, CPA – Chief Financial Officer

Mr. Livne has been serving as Chief Financial Officer since 2014. Before joining Bonus BioGroup, Mr. Livne was Chief Financial Officer at Bee Contact Communication Ltd., a publicly traded company (TASE), and Chief Controller at Dexcel Pharma, a privately held international pharmaceutical company. Mr. Livne holds an MBA in Finance and a BA in Accounting and Economics from The Hebrew University.

Vered Kivity, PhD, MBA – Head of Regulatory Affairs

Dr. Kivity is experienced in the global regulatory and clinical affairs landscape throughout the product's lifecycle, with managerial experience from pharma, biotechnological and medical device companies. Dr. Kivity has led the successful submissions to worldwide regulatory authorities (FDA, EMA, MHRA, CFDA, Health Canada, AEMPS, the Israeli ministry of Health, PMDA). Dr. Kivity holds a PhD degree and an MBA degree from the Technion, the Israeli institute of Technology, and authored nine peer reviewed scientific articles and two book chapters.

Image
Image

In Memory of Avinoam Kadouri

The Bonus BioGroup family is mourning the loss of Prof. Avinoam Kadouri - Founder and Chief Technology Officer. Prof. Kadouri died unexpectedly in September 2016. He was a world-renowned and widely respected leader of industrial biotechnology and process development. Before joining Bonus BioGroup he served as Director at Serono International and Chairman of both ACTIP (Animal Cell Technology Industrial Platform) and the European Association for Bio-Industries. A central yet gentle man, his passing was received with great sadness by everyone in Bonus BioGroup. His deep commitment to the Company and his many contributions towards its establishment, early development and continued progress were insightful and valuable. He was a remarkable colleague and a dear friend. May he rest in peace.

FOR MORE INVESTOR RELATION INFORMATION

Press Release, Announcements publication and more

Bonus BioGroup

Image

 

Terms of UsePrivacy Policy | Login        

© 2021 Bonus BioGroup Ltd. All Rights Reserved. Designed By Netron Israel Ltd.
Accessibility Initiative Badge